Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
With $315M raise, AdvanCell puts radiotherapy pedal to the metal
With its new cash in hand, AdvanCell is positioned to stake its own claim in the surging field with a novel isotope, lead-212.
Darren Incorvaia
Jul 15, 2026 10:50am
J&J axes eye disease gene therapy after key phase 2b readout
Jul 15, 2026 10:26am
De-Risking a Rare Disease Launch Starts with Precision
Brought to you by
PANTHERx® Rare Pharmacy
Fierce Biotech Fundraising Tracker '26: AdvanCell, Draig & more
Jul 15, 2026 9:00am
AAIC: Roche ‘very interested’ in tau despite amyloid AD focus
Jul 15, 2026 8:42am
Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent
Jul 15, 2026 4:09am
More News
Fierce Pharma
Celcuity set to be Big Pharma 'strategic target' after approval
Jul 14, 2026 4:56pm
FDA plans to release more CRLs as controversial policy resumes
Jul 14, 2026 2:50pm
Biogen defends anti-tau drug after stock slide
Jul 14, 2026 2:00pm
First Bundibugyo Ebola vaccine to enter phase 1 trials
Jul 14, 2026 12:18pm
See more stories